Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEREMY M COX

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1972831618
CMS profile
89182
Location
RIVERSIDE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,236.61

33 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,084.51 32
Travel and Lodging $152.10 1

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEREMY M COX

NPI 1972831618 · CMS profile ID 89182

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

RIVERSIDE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972831618?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEREMY M COX, NPI 1972831618, CMS profile ID 89182. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972831618?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JEREMY M COX, NPI 1972831618, CMS profile ID 89182. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972831618?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JEREMY M COX, NPI 1972831618, CMS profile ID 89182, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1972831618?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

33 matching records · $1,236.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 33 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–33 of 33.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $11.9612/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982101 CMS
Novartis Pharmaceuticals Corporation $7.2111/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982107 CMS
Janssen Pharmaceuticals, Inc $11.3711/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658467535 CMS
Novartis Pharmaceuticals Corporation $18.7611/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982103 CMS
Medtronic Vascular, Inc. $11.2311/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 677098955 CMS
PFIZER INC. $95.3210/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673316979 CMS
Amgen Inc. $5.7610/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662500359 CMS
Novartis Pharmaceuticals Corporation $0.9310/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982097 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $49.1408/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 625116475 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $49.1408/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 625116477 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.3308/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700264167 CMS
Novartis Pharmaceuticals Corporation $12.5108/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982089 CMS
Novartis Pharmaceuticals Corporation $17.3407/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982085 CMS
Novartis Pharmaceuticals Corporation $125.0007/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982093 CMS
Novartis Pharmaceuticals Corporation $7.0006/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982067 CMS
Alnylam Pharmaceuticals Inc. $124.9905/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701568983 CMS
SANOFI-AVENTIS U.S. LLC $22.5005/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694107501 CMS
PFIZER INC. $20.0004/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673751129 CMS
Novartis Pharmaceuticals Corporation $4.5303/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982077 CMS
Novartis Pharmaceuticals Corporation $7.4103/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982073 CMS
Medtronic Vascular, Inc. $42.3402/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 676892099 CMS
SANOFI-AVENTIS U.S. LLC $24.3702/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693925597 CMS
PFIZER INC. $5.1002/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673295791 CMS
PFIZER INC. $4.2001/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673295415 CMS
Amgen Inc. $46.2301/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334539 CMS
Amgen Inc. $23.1101/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334543 CMS
Amgen Inc. $46.2301/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334545 CMS
Amgen Inc. $23.1101/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334549 CMS
Amgen Inc. $152.1001/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334535 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.3901/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700264169 CMS
Medtronic Vascular, Inc. $33.3301/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 676892061 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $68.6701/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 625116473 CMS
Novartis Pharmaceuticals Corporation $125.0001/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982081 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,236.61 33
PY2020 $212.17 5
PY2021 $47.87 3
PY2022 $539.01 32
PY2023 $462.93 21
PY2024 $289.60 16
PY2025 $360.31 17

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $37,178.60 24
PY2021 Principal investigator $69,598.51 32
PY2020 Principal investigator $153,961.23 91
PY2019 Principal investigator $248,597.19 151

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

91 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 12/07/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913805
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 12/07/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913807
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 11/10/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913707
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 11/10/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913709
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 11/10/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913711
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 11/10/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913713
Principal investigator 1 Amgen Inc. $2,370.40 11/09/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
VESALIUS - CV No dispute reported 06/30/2026 753888931
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $508.29 10/31/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750757927
Principal investigator 1 Amgen Inc. $2,875.00 10/24/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
VESALIUS - CV No dispute reported 06/30/2026 731644743
Principal investigator 1 Boehringer Ingelheim International GmbH $43.55 10/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913801
Principal investigator 1 Boehringer Ingelheim International GmbH $27.16 10/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913803
Principal investigator 1 Boehringer Ingelheim International GmbH $65.32 10/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913809
Principal investigator 1 Boehringer Ingelheim International GmbH $27.16 10/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913811
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $6,607.75 09/30/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750757923
Principal investigator 1 Boehringer Ingelheim International GmbH $4,270.90 09/17/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913723
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 09/10/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913715
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 09/10/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913717
Principal investigator 1 Boehringer Ingelheim International GmbH $1,051.00 08/18/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913731
Principal investigator 1 Boehringer Ingelheim International GmbH $58.47 08/18/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913761
Principal investigator 1 Amgen Inc. $925.19 08/10/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
GALACTIC - HF No dispute reported 06/30/2026 731631231
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 08/07/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913725
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 08/07/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913729
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,574.60 07/31/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750757925
Principal investigator 1 PFIZER INC. $7,184.94 07/23/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 742940661
Principal investigator 1 PFIZER INC. $378.21 07/23/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 742940953
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 07/07/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913727
Principal investigator 1 Boehringer Ingelheim International GmbH $64.89 07/03/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913719
Principal investigator 1 Boehringer Ingelheim International GmbH $64.89 07/03/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913721
Principal investigator 1 Boehringer Ingelheim International GmbH $767.50 07/01/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913733
Principal investigator 1 Boehringer Ingelheim International GmbH $767.50 07/01/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913735
Principal investigator 1 Boehringer Ingelheim International GmbH $767.50 07/01/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913737
Principal investigator 1 Boehringer Ingelheim International GmbH $767.50 07/01/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913739
Principal investigator 1 Boehringer Ingelheim International GmbH $767.50 07/01/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913741
Principal investigator 1 Boehringer Ingelheim International GmbH $767.50 07/01/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913743
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 06/24/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913759
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 06/17/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913699
Principal investigator 1 Boehringer Ingelheim International GmbH $1,291.00 06/16/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913691
Principal investigator 1 Boehringer Ingelheim International GmbH $1,000.00 06/16/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913697
Principal investigator 1 Boehringer Ingelheim International GmbH $1,291.00 06/16/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913819
Principal investigator 1 Amgen Inc. $11.16 06/08/2020 Non-covered Recipient Entity
CARDIOLOGY SPECIALISTS MEDICAL GROUP
GALACTIC - HF No dispute reported 06/30/2026 731630923
Principal investigator 1 Amgen Inc. $10,711.20 06/08/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
VESALIUS - CV No dispute reported 06/30/2026 731644747
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 06/05/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913693
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 06/05/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913695
Principal investigator 1 Boehringer Ingelheim International GmbH $27.81 06/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913683
Principal investigator 1 Boehringer Ingelheim International GmbH $27.81 06/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913685
Principal investigator 1 Boehringer Ingelheim International GmbH $23.13 06/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913687
Principal investigator 1 Boehringer Ingelheim International GmbH $2.00 06/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913689
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 06/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913817
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,049.73 05/31/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750757921
Principal investigator 1 PFIZER INC. $454.60 05/27/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 742962551
Principal investigator 1 Amgen Inc. $1,099.00 05/20/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
GALACTIC - HF No dispute reported 06/30/2026 731631235
Principal investigator 1 Boehringer Ingelheim International GmbH $1,291.00 05/12/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913705
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 05/12/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913749
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 05/12/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913813
Principal investigator 1 Boehringer Ingelheim International GmbH $685.00 04/17/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913701
Principal investigator 1 Boehringer Ingelheim International GmbH $1,000.00 04/17/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913751
Principal investigator 1 Boehringer Ingelheim International GmbH $1,000.00 04/17/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913753
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 04/14/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913745
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 04/14/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913747
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 04/14/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913755
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 04/14/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913757
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 04/01/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913703
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,574.60 03/31/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750757917
Principal investigator 1 PFIZER INC. $226.94 03/26/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 742962483
Principal investigator 1 Amgen Inc. $26,890.00 03/24/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
VESALIUS - CV No dispute reported 06/30/2026 731644751
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 03/12/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913775
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 03/10/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913773
Principal investigator 1 Boehringer Ingelheim International GmbH $51.65 03/03/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913781
Principal investigator 1 Boehringer Ingelheim International GmbH $51.65 03/03/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913785
Principal investigator 1 Boehringer Ingelheim International GmbH $34.60 03/03/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913799
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 02/25/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913777
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 02/25/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913779
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 02/25/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913787
Principal investigator 1 Amgen Inc. $2,123.00 02/22/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
GALACTIC - HF No dispute reported 06/30/2026 731631227
Principal investigator 1 Amgen Inc. $2,924.04 02/19/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
VESALIUS - CV No dispute reported 06/30/2026 731644755
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 02/17/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913789
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 02/17/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913791
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 02/17/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913793
Principal investigator 1 Amgen Inc. $152.30 02/10/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
GALACTIC - HF No dispute reported 06/30/2026 731631239
Principal investigator 1 Boehringer Ingelheim International GmbH $2.21 02/05/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913783
Principal investigator 1 Boehringer Ingelheim International GmbH $25.55 02/05/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913795
Principal investigator 1 Boehringer Ingelheim International GmbH $2.21 02/05/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913797
Principal investigator 1 Boehringer Ingelheim International GmbH $25.55 02/05/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913815
Principal investigator 1 Amgen Inc. $30,765.00 01/31/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
VESALIUS - CV No dispute reported 06/30/2026 731644739
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $508.29 01/31/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 750757919
Principal investigator 1 Boehringer Ingelheim International GmbH $1,204.00 01/28/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913767
Principal investigator 1 PFIZER INC. $226.94 01/08/2020 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 742977629
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 01/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913763
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 01/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913765
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 01/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913769
Principal investigator 1 Boehringer Ingelheim International GmbH $1,291.00 01/02/2020 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749913771